CD19/CD22 CAR-T therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD19/CD22 CAR-T therapy, covering 2024-10-17 to 2024-10-17. Get the full timeline:
Most recent: Clinical Trial Update: Sequential CD19 and CD22 CAR-T Therapy for Newly Diagnosed Ph+ B-ALL [Phase 2]